Journal of Inherited Metabolic Disease

, Volume 21, Issue 4, pp 341–350 | Cite as

Molecular characterization of a unique patient with epimerase-deficiency galactosaemia

  • A. Alano
  • S. Almashanu
  • J. M. Chinsky
  • P. Costeas
  • M. G. Blitzer
  • E. A. Wulfsberg
  • T. M. Cowan
Article

Abstract

Inherited deficiencies of UDP-galactose 4-epimerase (GALE) havebeen associated with two distinct phenotypes. The vast majority of North American patients are clinically asymptomatic, are identified through newborn screening programmes for classical galactosaemia, and are of African-American descent. At least two symptomatic patients have been reported, one Pakistani and the other Asian Muslim, both with severe complications in the neonatal period and subsequent mental retardation. Through newborn screening, we have identified a GALE-deficient patient who is of mixed Pakistani/caucasian ancestry. He was clinically well in the neonatal period on a lactose-containing diet, and biochemical studies, including urine reducing sugars and galactitol, were consistent with a diagnosis of peripheral GALE deficiency. Although early developmental milestones were met normally, he now shows significant developmental delays in both motor and language skills. Mutational analysis revealed this patient to be a compound heterozygote at the GALE locus, with mutations N34S and L183P identified in the patient and confirmed in the parents. This report represents the first characterization of specific mutations ina GALE-deficient patient in conjunction with biochemical and clinical pheno-type, and facilitates further studies of the GALE enzyme and its role in the different clinical forms of epimerase-deficiency galactosaemia.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Alano A, Almashanu S, Maceratesi P, Reichardt J, Panny S, Cowan TM (1997) UDP-galactose-4′-epimerase deficiency among African Americans: evidence for multiple alleles. J Invest Med 45: 191A.Google Scholar
  2. Benn P, Shows TB, D'Ancona GG, Croee CM, Orrwiszewski KG, Mellman WJ (1979) Assignment of the gene for uridine diphosphate galactose-4-epimerase to human chromo-some 1 by somatic cell hybridization with evidence for a regional assignment to 1pter-1p21. Cytogenet Cell Genet 24: 138-142.Google Scholar
  3. Beutler E (1975) Red Cell Metabolism: A Manual of Biochemical Methods, 3rd edn. Orlando: Grune and Stratton.Google Scholar
  4. Daude N, Gallaher TK, Zeschinigk M, et al (1995) Molecular cloning, characterization and mapping of a full-length cDNA encoding human UDP-galactose-4-epimerase. Biochem Mol Med 56: 1-7.Google Scholar
  5. Gitzelmann R (1972) Deficiency of uridine diphosphate galactose-4-epimerase in blood cells of an apparently healthy infant. Helv Paediatr Acta 27: 125-130.Google Scholar
  6. Gitzelmann R, Steinmann B (1973) Uridine diphosphate galactose-4-epimerase deficiency. II. Clinical follow up, biochemical studies and family investigations. Helv Paediatr Acta 28: 497-510.Google Scholar
  7. Gitzelmann R, Steinmann B, Mitchell B, Haigis E (1976) Uridine diphosphate galactose 4-epimerase deficiency IV. Report of eight cases in three families. Helv Paediatr Acta 31: 441-452.Google Scholar
  8. Holton JB, Gillett MG, MacFaul R, Young R (1981) Galactosaemia: a new severe variant due to uridine diphosphate galactose-4-epimerase deficiency. Arch Dis Child 56: 885-887.Google Scholar
  9. Kingsley D, Kozarsky KF, Hobbie L, Drieger M (1986) Reversible defects in O-linked gly-cosylation and LDL-receptor expression in a UDP-Gal-UDP-GalNAc-4-epimerase deficient mutant. Cell 44: 749-759.Google Scholar
  10. Kirkman HN, Maxwell ES (1960) Enzymatic estimation of erythrocytic galactose-1-phosphate. J L ab Clin Med 56: 161-166.Google Scholar
  11. Levy HL, Hammersen G (1978) Newborn screening for galactosemia and other galactose metabolic defects. J Pediatr 92: 871-877.Google Scholar
  12. Lin MS, Oizumi J, Ng WG, Alfi OS, Donnel GN (1979) Regional mapping of the gene for human UDPGal4-epimerase on chromosome 1 in mouse-human hybrids. Cytogenet Cell Genet 24: 217-223.Google Scholar
  13. Misumi H, Wada H, Kawakami M, et al (1981) Detection of UDP-galactose-4-epimerase deficiency in a galactosaemia screening program. Clin Chim Acta 116: 101-105.Google Scholar
  14. Ng WG, Bergren WR, Donnell GN (1967) An improved procedure for the assay of hemolysate galactose-1-phosphate urdyl transferase activity by the use of [14C]-labelled galactose-1-phosphate. Clin Chim Acta 15: 489-492.Google Scholar
  15. Quimby BB, Alano A, Almashanu S, DeSandro AM, Cowan TM, Fridovich-Keil JL (1997) Characterization of two mutations associated with epimerase-deficiency galactosaemia using a yeast expression system for human UDP-galactose-4-epimerase. Am J Hum Genet 61: 590-598.Google Scholar
  16. Sardharwalla IB, Wraith JE, Bridge C, Fowler B, Roberts SA (1988) A patient with severe type of epimerase deficiency galactosaemia. J Inher Metab Dis 11: 249-251.Google Scholar
  17. Segal S, Berry GT (1995) Disorders of galactose metabolism. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. T he Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 453-480.Google Scholar
  18. Thoden JB, Frey PA, Holden HM (1996) Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli. Biochemistry 35: 2557-2566.Google Scholar
  19. Waggoner DD, Buist NRM, Donnell GN (1990) Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inher Metab Dis 13: 802.Google Scholar

Copyright information

© SSIEM and Kluwer Academic Publishers 1998

Authors and Affiliations

  • A. Alano
  • S. Almashanu
  • J. M. Chinsky
  • P. Costeas
  • M. G. Blitzer
  • E. A. Wulfsberg
  • T. M. Cowan

There are no affiliations available

Personalised recommendations